lobbying_activities: 2635920

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2635920	f834780d-9852-4c10-a098-f9713189b91e	Q2	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2021	second_quarter	PHA	PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population.	HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)	60000		0	0	2021-07-13T12:40:00.663000-04:00